|
Analysis of prognostic factors of clinical outcome in children and adolescents enrolled in phase I trials: a multicentre European collaborative study. |
| |
Fernando Carceller Lechon |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - MSD |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Novartis |
Travel, Accommodations, Expenses - Novartis |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Roche Pharma AG |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Roche Pharma AG |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Roche Pharma AG; ThromboGenics |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; Roche Pharma AG; ThromboGenics |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |